Accolade to Participate in Upcoming Investor Conferences
February 16 2021 - 8:00AM
Accolade, Inc. (NASDAQ: ACCD), which provides personalized,
technology-enabled solutions that help people better understand,
navigate, and utilize the healthcare system and their workplace
benefits, will participate in the following upcoming investor
conferences:
- The BTIG Virtual MedTech, Digital
Health, Life Science & Diagnostic Tools Conference, including a
fireside chat on Wednesday, February 17, 2021 at 4:00 p.m.
E.T.
- The SVB Leerink Global Healthcare
Conference, including a fireside chat presentation on Wednesday,
February 24, 2021 at 9:20 a.m. E.T.
The audio webcasts and related presentation materials from both
events will be available at ir.accolade.com.
About Accolade, Inc.
Accolade provides personalized health and benefits solutions
designed to empower every person to live their healthiest life.
Using a blend of cloud-based technologies, specialized support from
Accolade Health Assistants® and Clinicians, and integrated data and
programs across mobile, online and phone, Accolade navigates people
through the healthcare system with trust, empathy and ease.
Employers offer Accolade to employees and their families as the
single place to turn for all health, healthcare, and benefits
questions or concerns, increasing their engagement in benefits and
connecting them to high-quality providers and care. By empowering
members to make better decisions about their health, Accolade can
support members in lowering the cost and complexity of healthcare
while achieving consumer satisfaction ratings over 90 percent and
an NPS of 60.
Investor Contact:
Todd Friedman, Investor Relations, 484-532-5200,
Todd.Friedman@accolade.com
Asher Dewhurst, Investor Relations, 443-213-0503,
accolade@westwicke.com
Media Contact:
Megan Torres, Public Relations, 206-926-8180,
Megan.Torres@accolade.com
Source:
Accolade
Accolade (NASDAQ:ACCD)
Historical Stock Chart
From Apr 2024 to May 2024
Accolade (NASDAQ:ACCD)
Historical Stock Chart
From May 2023 to May 2024